Responses to parliamentary questions
Question from Deputy Ken O'Flynn - PQ 15815-26
Deputy O'Flynn asked about the full health technology assessment of tirzepatide for type 2 diabetes. Read the HSE response.
From: Communications and public affairs
Published: February 2026
Updated: March 2026
Documents
Question from Deputy Ken O'Flynn - PQ 15815-26
PDF, 571KB, 3 pages
Summary
To ask the Minister for Health the reasons for the duration between commissioning and completion of the full health technology assessment of tirzepatide for type 2 diabetes; and whether her Department has conducted any review of timelines in the medicines assessment process since 2023.
This is a beta version - your feedback will help us to improve it